Earnings Release • Apr 28, 2022
Earnings Release
Open in ViewerOpens in native device viewer
First quarter 2022
Kjerstin R. Braathen (CEO) Ida Lerner (CFO)
Q1 Sbanken included in balance sheet figures as of 31 March 2022, but not in average balance sheet or profit figures for the quarter.
28 April 2022
Return on equity (ROE) of 12.9 per cent in the quarter Strong performance in the customer segments and net reversals of impairment provisions
Net interest income (NII) up 13.2 per cent from 1Q21 and 1.6 from 4Q21 Driven by repricing and volume growth
Net commissions and fees up 8.1 per cent from 1Q21 Strong performance across product areas
Net reversals of impairment provisions Reflecting successful restructuring of customer-specific cases in stage 3 and an overall robust portfolio
Earnings per share (EPS) up 29 per cent from 1Q21 EPS of NOK 4.71 for the quarter
The acquisition of Sbanken approved 16 March 2022 Sbanken to remain separate entity until further details are in place
Sbanken showed strong growth in the quarter Loans to customers increased by 5.6 per cent
Determined to create the best digital customer experiences Combining two institutions with leading tech and innovation capabilities
Investments in Norway NOK billion (constant 2021 prices)
1) Core inflation, excluding energy and utility prices. Sources: DNB Markets, Norges Bank, Norwegian Ministry of Finance.
Savings volumes at end of period, NOK billion
Pre-tax operating profit
Before impairment provisions
1.79 1.69
0.50
0.30
| Impairment of financial instruments by industry segment NOK million (excluding Sbanken) |
Maximum exposure (on- and off-balance sheet items), net of accumulated impairment provisions (including Sbanken) |
|||||||
|---|---|---|---|---|---|---|---|---|
| 1Q22 | 4Q21 | 1Q21 | Stage 1 NOK 2 392 billion |
Stage 2 NOK 144 billion |
Stage 3 | |||
| Personal customers | (+124) | (+2) | (-2) | |||||
| - Stages 1 and 2 | 3 | (2) | 20 | |||||
| - Stage 3 | (39) | (62) | (44) | |||||
| Corporate customers | ||||||||
| - Stages 1 and 2 | 78 | 177 | 209 | 1.0% | ||||
| - Stage 3 | 547 | (388) | (74) | 93.4% | 5.6% | |||
| Total | 589 | (275) | 110 | |||||
NOK 25 billion (-2)
Financial Supervisory Authority of Norway's (FSA's) expectation increased to 17.7 per cent portfolio mix following inclusion of Sbanken impacting counter-cyclical and systemic risk buffer requirements
1) FSA's expectation including pre-pandemic counter-cyclical buffer requirements.
Appendix
| NOK million | 1Q22 | 4Q21 | 1Q21 | Change from 4Q21 |
Change from 1Q21 |
|---|---|---|---|---|---|
| Net interest income | 10 445 | 10 285 | 9 230 | 160 | 1 216 |
| Other operating income | 4 695 | 4 348 | 4 116 | 347 | 579 |
| Total income | 15 141 | 14 633 | 13 346 | 507 | 1 795 |
| Operating expenses | (5 966) | (6 427) | (5 817) | 461 | (149) |
| Pre-tax operating profit before impairment | 9 175 | 8 206 | 7 528 | 969 | 1 646 |
| Impairment of loans and guarantees and gains on assets | 590 | (251) | 107 | 841 | 483 |
| Pre-tax operating profit | 9 765 | 7 955 | 7 636 | 1 810 | 2 130 |
| Tax expense | (2 246) | (2 025) | (1 680) | (221) | (566) |
| Profit from operations held for sale, after taxes | 36 | 225 | (71) | (190) | 107 |
| Profit for the period | 7 555 | 6 155 | 5 885 | 1 400 | 1 670 |
| Portion attributable to shareholders | 7 299 | 5 875 | 5 665 | 1 424 | 1 634 |
| NOK million | 1Q22 | 4Q21 | 1Q21 | Change from 4Q21 |
Change from 1Q21 |
|---|---|---|---|---|---|
| Net commissions and fees | 2 844 | 3 049 | 2 631 | (205) | 213 |
| Customer revenues in DNB Markets | 626 | 653 | 502 | (27) | 123 |
| Trading revenues in DNB Markets | 386 | 2 | 69 | 383 | 317 |
| Hedging of defined-benefit pension scheme | (28) | 76 | 66 | (103) | (94) |
| Credit spreads on bonds | (144) | (75) | 153 | (70) | (298) |
| Credit spreads on fixed-rate loans | (285) | (67) | 81 | (218) | (366) |
| CVA/DVA/FVA | 48 | 1 | 241 | 47 | (193) |
| Other mark-to-market adjustments | 469 | (110) | 2 | 579 | 467 |
| Basis swaps | 629 | 100 | (345) | 529 | 974 |
| Exchange rate effects on additional Tier 1 capital | (138) | 125 | 29 | (263) | (167) |
| Net gains on financial instruments at fair value | 1 562 | 704 | 799 | 858 | 763 |
| Net financial and risk result, life insurance | 32 | 203 | 212 | (171) | (180) |
| Profit from investments accounted for by the equity method | (15) | (6) | 86 | (8) | (100) |
| Other | 272 | 397 | 389 | (125) | (116) |
| Net other operating income, total | 4 695 | 4 348 | 4 116 | 347 | 579 |
The statements contained in this presentation may include forward-looking statements, such as statements of future expectations. These statements are based on the management's current views and assumptions and involve both known and unknown risks and uncertainties.
Although DNB believes that the expectations implied in any such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to be correct.
Actual results, performance or events may differ materially from those set out or implied in the forward-looking statements. Important factors that may cause such a difference include, but are not limited to: (i) general economic conditions, (ii) performance of financial markets, including market volatility and liquidity, (iii) the extent of credit defaults, (iv) interest rate levels, (v) currency exchange rates, (vi) changes in the competitive climate, (vii) changes in laws and regulations, (viii) changes in the policies of central banks and/or foreign governments, or supranational entities.
DNB assumes no obligation to update any forward-looking statement.
This presentation contains alternative performance measures, or non-IFRS financial measures. Definitions and calculations are presented on ir.dnb.no.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.